GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Share Analysis
NSE · Healthcare · Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 21 Sep 2026, the share price was ₹2,839.00, market capitalisation ₹48,091 Cr, P/E 45.7, ROE 45.6%.
Get the AI verdict on GLAXO: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
GLAXO price and valuation
- Share price
- ₹2,839.00
- Market cap
- ₹48,091 Cr
- P/E ratio
- 45.7
- P/B ratio
- 21.19
- EPS
- ₹63.05
- Book value per share
- ₹134.00
- Dividend yield
- 2.01%
GLAXO profitability and growth
- ROE
- 45.6%
- ROCE
- 61.4%
- Debt to equity
- 0.01
- Revenue growth (3 yr)
- 6%
- Revenue growth (5 yr)
- 5%
- Profit growth (3 yr)
- 18%
- Profit growth (5 yr)
- 15%
GLAXO 52-week range
- 52-week high
- ₹3,120.70
- 52-week low
- ₹2,088.10
- Face value
- ₹10.00
GLAXO shareholding pattern
- Promoters
- 75%
- FIIs
- 4.79%
- DIIs
- 7.81%
- Public
- 12.42%
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.